Asahi Kasei Pharma starts Phase III study of promising CIPN prevention therapy
ART-123 is a recombinant human thrombomodulin approved in Japan in 2008
ART-123 is a recombinant human thrombomodulin approved in Japan in 2008
The iStent platform uses tiny surgical implants to lower eye pressure by restoring the eye’s natural fluid drainage system in patients with glaucoma
Over 100 million cartridges of rh-insulin supplied to Malaysian health ministry; 345,000+ patients served
Changhua site meets international regulatory standards for global medical applications
The GMP-compliant facility with automated environmental monitoring accommodates both white room and class 7 and 8 cleanroom space
The partnership combines Boehringer’s expertise in canine cardiology with Eko’s digital stethoscopes and AI algorithms
The 16,000-square-foot expansion enhances DuPont’s global sterile operations
Scores highest PAT of Rs. 118 crore in FY25
Ami Organics’ Ankleshwar Unit II gets GMP compliant by PMDA Japan
Subscribe To Our Newsletter & Stay Updated